The deal gives Merck access to Verona Pharma’s new chronic obstructive pulmonary disease medication Ohtuvayre.

Chronic obstructive pulmonary disease (COPD) is a lung condition that often hides in plain sight. You may think you're ...

Sue’s recommendation to others living with COPD is to not isolate yourself and stay at home. It is okay to ask for help and ...

COPD, or chronic obstructive pulmonary disease, affects more than 30 million Americans, yet many have never heard of it. COPD ...

Cite this: Relationship Between Pulmonary Emphysema and Osteoporosis Assessed by CT in Patients With COPD - Medscape - Dec 01, 2008. Abstract and Introduction Materials and Methods ...

Tina Tucker said Monday she was able to find “some solace” knowing she had the opportunity to tell her husband she loved him ...

SAN FRANCISCO — Among patients with COPD and type 2 inflammation, investigator-reported emphysema did not change benefits seen with dupilumab, according to research presented at the American ...

Smoking, air pollution and several other factors have led to significant disparities in lung health across the U.S.

Researchers have found in two longitudinal cohorts that Incorporating chest CT imaging and respiratory symptoms into the ...

Prevalence of chronic obstructive pulmonary disease (COPD) and the disease's burden varies significantly by state.

Merck & Co. said Wednesday it will acquire London-based Verona Pharma in a $10 billion all-cash deal, bolstering its respiratory treatment portfolio as the company moves to reduce long-term dependence ...

Digital inhalers may help predict impending acute exacerbations of chronic obstructive pulmonary disease (COPD), according to ...